Anti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets

被引：16

作者：

Adamson, Catherine S. ^{[1
]}

Freed, Eric O. ^{[1
]}

机构：

[1] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA

来源：

MOLECULAR INTERVENTIONS | 2009年 / 9卷 / 02期

关键词：

SMALL-MOLECULE INHIBITION; HIV-1 CAPSID PROTEIN; ASSEMBLY INHIBITOR; ENTRY INHIBITORS; TERMINAL DOMAIN; INTEGRASE; INFECTION; LEDGF/P75; COMPLEX; REPLICATION;

D O I：

10.1124/mi.9.2.5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：70 / 74

页数：5

共 44 条

[1] Recent progress in antiretrovirals - lessons from resistance [J].

Adamson, Catherine S. ;

Freed, Eric O. .

DRUG DISCOVERY TODAY, 2008, 13 (9-10) :424-432

[2] Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein [J].

Bartonova, Vanda ;

Igonet, Sebastien ;

Sticht, Jana ;

Glass, Baerbel ;

Habermann, Anja ;

Vaney, Marie-Christine ;

Sehr, Peter ;

Lewis, Joe ;

Rey, Felix A. ;

Kraeusslich, Hans-Georg .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (46) :32024-32033

[3] Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase [J].

Cherepanov, P ;

Devroe, E ;

Silver, PA ;

Engelman, A .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48883-48892

[4] Novel Targets for Antiretroviral Therapy Clinical Progress to Date [J].

Dau, Birgitt ;

Holodniy, Mark .

DRUGS, 2009, 69 (01) :31-50

[5] Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication [J].

De Rijck, Jan ;

Vandekerckhove, Linos ;

Gijsbers, Rik ;

Hombrouck, Anneleen ;

Hendrix, Jelle ;

Vercammen, Jo ;

Engelborghs, Yves ;

Christ, Frauke ;

Debyser, Zeger .

JOURNAL OF VIROLOGY, 2006, 80 (23) :11498-11509

[6] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].

Dean, M ;

Carrington, M ;

Winkler, C ;

Huttley, GA ;

Smith, MW ;

Allikmets, R ;

Goedert, JJ ;

Buchbinder, SP ;

Vittinghoff, E ;

Gomperts, E ;

Donfield, S ;

Vlahov, D ;

Kaslow, R ;

Saah, A ;

Rinaldo, C ;

Detels, R ;

OBrien, SJ .

SCIENCE, 1996, 273 (5283) :1856-1862

[7] Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function [J].

Demirov, DG ;

Ono, A ;

Orenstein, JM ;

Freed, EO .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :955-960

[8] Retrovirus budding [J].

Demirov, DG ;

Freed, EO .

VIRUS RESEARCH, 2004, 106 (02) :87-102

[9] HIV entry inhibitors [J].

Este, Jose A. ;

Telenti, Amalio .

LANCET, 2007, 370 (9581) :81-88

[10] HIV-1 and the host cell: an intimate association [J].

Freed, EO .

TRENDS IN MICROBIOLOGY, 2004, 12 (04) :170-177

← 1 2 3 4 5 →